HP-161

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHP-161
Drug Alias NameGrowth Factor Inhibitor (Stainwei Biotech)Angiogenesis Inhibitor (Stainwei Biotech)HP-161
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGrowth factor receptors antagonists
TargetsGrowth factor receptors
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSuzhou Stainwei Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuzhou Stainwei Biotech Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A